MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  Forster, Samuel C ^a,b,c   Tate, Michelle D ^a,b   Hertzog, Paul J ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Interferon; Interferon regulated genes; microRNA; Post transcriptional regulation; Systems biology

Indexed keywords

INTERFERON; MICRORNA;

BIOGENESIS; CELL DIFFERENTIATION; CELL FATE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE SILENCING; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA PROCESSING; SHORT SURVEY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

EID: 84935112583     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00334     Document Type: Short Survey

References (88)

1. L. A. O'Neill, D. Golenbock and A. G. Bowie: The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol, 13(6), 453-60 (2013) doi:10.1038/nri3446.
2. T. Maekawa, T. A. Kufer and P. Schulze-Lefert: NLR functions in plant and animal immune systems: so far and yet so close. Nat Immunol, 12(9), 817-26 (2011) doi:10.1038/ni.2083.
3. Y. M. Loo and M. Gale, Jr.: Immune signaling by RIG-I-like receptors. Immunity, 34(5), 680-92 (2011) doi:10.1016/j.im muni. 2011.05.003.
4. S. Forster: Interferon signatures in immune disorders and disease. Immunol Cell Biol, 90(5), 520-7 (2012) doi:10.1038/icb.2012.12.
5. I. Rusinova, S. Forster, S. Yu, A. Kannan, M. Masse, H. Cumming, R. Chapman and P. J. Hertzog: Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res, 41(Database issue), D1040-6 (2013) doi:10.1093/nar/gks1215.
6. K. Oda and H. Kitano: A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol, 2, 2006 0015 (2006) doi:10.1038/msb4100057.
7. P. Hertzog, S. Forster and S. Samarajiwa: Systems biology of interferon responses. J Interferon Cytokine Res, 31(1), 5-11 (2011) doi:10.1089/jir.2010.0126.
8. H. M. Lee, D. T. Nguyen and L. F. Lu: Progress and challenge of microRNA research in immunity. Front Genet, 5, 178 (2014) doi:10.3389/fgene.2014.00178.
9. M. Ha and V. N. Kim: Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol, 15(8), 509-24 (2014) doi:10.1038/nrm3838.
10. E. Huntzinger and E. Izaurralde: Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet, 12(2), 99-110 (2011) doi:10.1038/nrg2936.
11. K. N. Ivey and D. Srivastava: MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell, 7(1), 36-41 (2010) doi:10.1016/j.stem.2010.06.012.
12. M. V. Iorio and C. M. Croce: Causes and consequences of microRNA dysregulation. Cancer J, 18(3), 215-22 (2012) doi:10.1097/PPO.0b013e318250c001.
13. J. Lu, G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz and T. R. Golub: MicroRNA expression profiles classify human cancers. Nature, 435(7043), 834-8 (2005) doi:10.1038/nature03702.
14. H. Schwarzenbach, N. Nishida, G. A. Calin and K. Pantel: Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol, 11(3), 145-56 (2014) doi:10.1038/nrclinonc.2014.5.
15. L. M. Sedger: microRNA control of interferons and interferon induced anti-viral activity. Mol Immunol, 56(4), 781-93 (2013) doi:10.1016/j.molimm.2013.07.009.
16. P. J. Hertzog and B. R. Williams: Fine tuning type I interferon responses. Cytokine Growth Factor Rev, 24(3), 217-25 (2013) doi:10.1016/j.cytogfr.2013.04.002.
17. N. A. de Weerd, J. P. Vivian, T. K. Nguyen, N. E. Mangan, J. A. Gould, S. J. Braniff, L. Zaker-Tabrizi, K. Y. Fung, S. C. Forster, T. Beddoe, H. H. Reid, J. Rossjohn and P. J. Hertzog: Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1. Nat Immunol, 14(9), 901-7 (2013) doi:10.1038/ni.2667.
18. K. D. Taganov, M. P. Boldin, K. J. Chang and D. Baltimore: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA, 103(33), 12481-6 (2006) doi:10.1073/pnas.0605298103.
19. J. Hou, P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang and X. Cao: MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol, 183(3), 2150-8 (2009) doi:10.4049/jimmunol.0900707.
20. D. T. Starczynowski, F. Kuchenbauer, J. Wegrzyn, A. Rouhi, O. Petriv, C. L. Hansen, R. K. Humphries and A. Karsan: MicroRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol, 39(2), 167- 178 e4 (2011) doi:10.1016/j.exphem.2010.09.011.
21. Y. Tang, X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P. P. Tak, S. Chen and N. Shen: MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum, 60(4), 1065-75 (2009) doi:10.1002/art.24436.
22. J. E. Cameron, Q. Yin, C. Fewell, M. Lacey, J. McBride, X. Wang, Z. Lin, B. C. Schaefer and E. K. Flemington: Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol, 82(4), 1946-58 (2008) doi:10.1128/JVI.02136-07.
23. M. P. Boldin, K. D. Taganov, D. S. Rao, L. Yang, J. L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, G. Sun, J. Tay, P. S. Linsley and D. Baltimore: miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med, 208(6), 1189-201 (2011) doi:10.1084/jem. 20101823.
24. J. L. Zhao, D. S. Rao, M. P. Boldin, K. D. Taganov, R. M. O'Connell and D. Baltimore: NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl AcadSci USA, 108(22), 9184-9 (2011) doi:10.1073/pnas. 1105398108.
25. E. Tili, J. J. Michaille, V. Gandhi, W. Plunkett, D. Sampath and G. A. Calin: miRNAs and their potential for use against cancer and other diseases. Future Oncol, 3(5), 521-37 (2007) doi:10.2217/14796694.3.5.521.
26. R. M. O'Connell, K. D. Taganov, M. P. Boldin, G. Cheng and D. Baltimore: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA, 104(5), 1604-9 (2007) doi:10.1073/pnas. 0610731104.
27. S. R. Quinn, N. E. Mangan, B. E. Caffrey, M. P. Gantier, B. R. Williams, P. J. Hertzog, C. E. McCoy and L. A. O'Neill: The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10. J Biol Chem, 289(7), 4316-25 (2014) doi:10.1074/jbc.M 113.522730.
28. E. Tili, J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin and C. M. Croce: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol, 179(8), 5082-9 (2007).
29. I. Dunand-Sauthier, M. L. Santiago-Raber, L. Capponi, C. E. Vejnar, O. Schaad, M. Irla, Q. Seguin- Estevez, P. Descombes, E. M. Zdobnov, H. Acha-Orbea and W. Reith: Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood, 117(17), 4490-500 (2011) doi:10.1182/blood-2010-09-308064.
30. R. T. Martinez-Nunez, F. Louafi, P. S. Friedmann and T. Sanchez-Elsner: MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem, 284(24), 16334-42 (2009) doi:10.1074/jbc.M 109.011601.
31. H. Zhou, X. Huang, H. Cui, X. Luo, Y. Tang, S. Chen, L. Wu and N. Shen: miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood, 116(26), 5885-94 (2010) doi:10.1182/blood-2010-04-280156.
32. K. Kobayashi, L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov and R. A. Flavell: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell, 110(2), 191-202 (2002).
33. L. Philippe, G. Alsaleh, G. Suffert, A. Meyer, P. Georgel, J. Sibilia, D. Wachsmann and S. Pfeffer: TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. J Immunol, 188(1), 454-61 (2012) doi:10.4049/jimmunol. 1102348.
34. A. Androulidaki, D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis and C. Tsatsanis: The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity, 31(2), 220-31 (2009) doi:10.1016/j.immuni.2009.06.024.
35. E. B. Wendlandt, J. W. Graff, T. L. Gioannini, A. P. McCaffrey and M. E. Wilson: The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-kappaB activation. Innate Immun, 18(6), 846-55 (2012) doi:10.1177/1753425912443903.
36. Y. Li, X. Fan, X. He, H. Sun, Z. Zou, H. Yuan, H. Xu, C. Wang and X. Shi: MicroRNA-466l inhibits antiviral innate immune response by targeting interferon-alpha. Cell Mol Immunol, 9(6), 497-502 (2012) doi:10.1038/cmi.2012.35.
37. K. W. Witwer, J. M. Sisk, L. Gama and J. E. Clements: MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J Immunol, 184(5), 2369-76 (2010) doi:10.4049/jimmunol.0902712.
38. A. S. Papadopoulou, J. Dooley, M. A. Linterman, W. Pierson, O. Ucar, B. Kyewski, S. Zuklys, G. A. Hollander, P. Matthys, D. H. Gray, B. De Strooper and A. Liston: The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-alpha receptor. Nat Immunol, 13(2), 181-7 (2012) doi:10.1038/ni.2193.
39. C. Zhou, Q. Yu, L. Chen, J. Wang, S. Zheng and J. Zhang: A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Gene, 507(1), 95-8 (2012) doi:10.1016/j.gene.2012.06.073.
40. R. A. Piganis, N. A. De Weerd, J. A. Gould, C. W. Schindler, A. Mansell, S. E. Nicholson and P. J. Hertzog: Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J Biol Chem, 286(39), 33811-8 (2011) doi:10.1074/jbc. M111.270207.
41. S. Jiang, H. W. Zhang, M. H. Lu, X. H. He, Y. Li, H. Gu, M. F. Liu and E. D. Wang: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70(8), 3119-27 (2010) doi:10.1158/0008-5472.CAN-09-4250.
42. P. Wang, J. Hou, L. Lin, C. Wang, X. Liu, D. Li, F. Ma, Z. Wang and X. Cao: Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol, 185(10), 6226-33 (2010) doi:10.4049/jimmunol. 1000491.
43. A. Li, W. Song, J. Qian, Y. Li, J. He, Q. Zhang, W. Li, A. Zhai, W. Kao, Y. Hu, H. Li, J. Wu, H. Ling, Z. Zhong and F. Zhang: MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. IntJ Biochem Cell Biol, 45(4), 858-65 (2013) doi:10.1016/j.biocel.2013.01.008.
44. R. Yao, Y. L. Ma, W. Liang, H. H. Li, Z. J. Ma, X. Yu and Y. H. Liao: MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One, 7(10), e46082 (2012) doi:10.1371/journal.pone.0046082.
45. F. Pichiorri, S. S. Suh, M. Ladetto, M. Kuehl, T. Palumbo, D. Drandi, C. Taccioli, N. Zanesi, H. Alder, J. P. Hagan, R. Munker, S. Volinia, M. Boccadoro, R. Garzon, A. Palumbo, R. I. Aqeilan and C. M. Croce: MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci US A, 105(35), 12885-90 (2008) doi:10.1073/pnas.0806202105.
46. C. Su, Z. Hou, C. Zhang, Z. Tian and J. Zhang: Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J, 8, 354 (2011) doi:10.1186/1743- 422X-8-354.
47. G. Kohanbash and H. Okada: MicroRNAs and STAT interplay. Semin Cancer Biol, 22(1), 70-5 (2012) doi:10.1016/j.semcancer.2011.12.010.
48. A. Mukherjee, A. M. Di Bisceglie and R. B. Ray: Hepatitis C Virus-Mediated Enhancement of MicroRNA miR-373 Impairs the JAK/STAT Signaling Pathway. J Virol, 89(6), 3356-65 (2015) doi:10.1128/JVI.03085-14.
49. A. Haghikia, M. Hoch, B. Stapel and D. Hilfiker-Kleiner: STAT3 regulation of and by microRNAs in development and disease. JAKSTAT, 1(3), 143-50 (2012) doi:10.4161/jkst.19573.
50. I. M. Pedersen, G. Cheng, S. Wieland, S. Volinia, C. M. Croce, F. V. Chisari and M. David: Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature, 449(7164), 919-22 (2007) doi:10.1038/nature06205.
51. Y. Li, T. Masaki, D. Yamane, D. R. McGivern and S. M. Lemon: Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci USA, 110(5), 1881-6 (2013) doi:10.1073/pnas.1213515110.
52. M. Ohno, A. Natsume, Y. Kondo, H. Iwamizu, K. Motomura, H. Toda, M. Ito, T. Kato and T. Wakabayashi: The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol Cancer Res, 7(12), 2022-30 (2009) doi:10.1158/1541-7786.MCR-09-0319.
53. C. Scagnolari, P. Zingariello, J. Vecchiet, C. Selvaggi, D. Racciatti, G. Taliani, E. Riva, E. Pizzigallo and G. Antonelli: Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Virol J, 7, 311 (2010) doi:10.1186/1743-422X-7-311.
54. P. Wang, Y. Gu, Q. Zhang, Y. Han, J. Hou, L. Lin, C. Wu, Y. Bao, X. Su, M. Jiang, Q. Wang, N. Li and X. Cao: Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. J Immunol, 189(1), 211-21 (2012) doi:10.4049/jimmunol. 1200609.
55. M. Hecker, M. Thamilarasan, D. Koczan, I. Schroder, K. Flechtner, S. Freiesleben, G. Fullen, H. J. Thiesen and U. K. Zettl: MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. IntJ MolSci, 14(8), 16087-110 (2013) doi:10.3390/ijms140816087.
56. C. Cilloniz, M. J. Pantin-Jackwood, C. Ni, V. S. Carter, M. J. Korth, D. E. Swayne, T. M. Tumpey and M. G. Katze: Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival. J Virol, 86(5), 2437-46 (2012) doi:10.1128/JVI.06156-11.
57. K. M. Dhodapkar, D. Banerjee, J. Connolly, A. Kukreja, E. Matayeva, M. C. Veri, J. V. Ravetch, R. M. Steinman and M. V. Dhodapkar: Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med, 204(6), 1359- 69 (2007) doi:10.1084/jem.20062545.
58. A. Turchinovich and B. Burwinkel: Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol, 9(8), 1066-75 (2012) doi:10.4161/rna.21083.
59. J. L. Wiesen and T. B. Tomasi: Dicer is regulated by cellular stresses and interferons. Mol Immunol, 46(6), 1222-8 (2009) doi:10.1016/j.molimm.2008.11.012.
60. D. J. Luciano, H. Mirsky, N. J. Vendetti and S. Maas: RNA editing of a miRNA precursor. RNA, 10(8), 1174-7 (2004) doi:10.1261/rna.7350304.
61. C. H. Lecellier, P. Dunoyer, K. Arar, J. Lehmann-Che, S. Eyquem, C. Himber, A. Saib and O. Voinnet: A cellular microRNA mediates antiviral defense in human cells. Science, 308(5721), 557-60 (2005) doi:10.1126/science.1108784.
62. M. B. Wang and M. Metzlaff: RNA silencing and antiviral defense in plants. Curr Opin Plant Biol, 8(2), 216-22 (2005) doi:10.1016/j.pbi.2005.01.006.
63. Y. Chen, A. Shen, P. J. Rider, Y. Yu, K. Wu, Y. Mu, Q. Hao, Y. Liu, H. Gong, Y. Zhu, F. Liu and J. Wu: A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEBJ, 25(12), 4511-21 (2011) doi:10.1096/fj.11-187781.
64. C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon and P. Sarnow: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science, 309(5740), 1577-81 (2005) doi:10.1126/science. 1113329.
65. R. Nathans, C. Y. Chu, A. K. Serquina, C. C. Lu, H. Cao and T. M. Rana: Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell, 34(6), 696-709 (2009) doi:10.1016/j.molcel.2009.06.003.
66. J. T. Perez, A. M. Pham, M. H. Lorini, M. A. Chua, J. Steel and B. R. tenOever: MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol, 27(6), 572-6 (2009) doi:10.1038/nbt.1542.
67. J. Brennecke, A. Stark, R. B. Russell and S. M. Cohen: Principles of microRNA-target recognition. PLoS Biol, 3(3), e85 (2005) doi:10.1371/journal.pbio.0030085.
68. D. P. Bartel: MicroRNAs: target recognition and regulatory functions. Cell, 136(2), 215-33 (2009) doi:10.1016/j.cell.2009.01.002.
69. B. P. Lewis, C. B. Burge and D. P. Bartel: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120(1), 15-20 (2005) doi:10.1016/j.cell.2004.12.035.
70. S. W. Chi, G. J. Hannon and R. B. Darnell: An alternative mode of microRNA target recognition. Nat Struct Mol Biol, 19(3), 321-7 (2012) doi:10.1038/nsmb.2230.
71. D. Didiano and O. Hobert: Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat Struct Mol Biol, 13(9), 849-51 (2006) doi:10.1038/nsmb1138.
72. A. Lal, F. Navarro, C. A. Maher, L. E. Maliszewski, N. Yan, E. O'Day, D. Chowdhury, D. M. Dykxhoorn, P. Tsai, O. Hofmann, K. G. Becker, M. Gorospe, W. Hide and J. Lieberman: miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell, 35(5), 610-25 (2009) doi:10.1016/j.molcel.2009.08.020.
73. G. B. Loeb, A. A. Khan, D. Canner, J. B. Hiatt, J. Shendure, R. B. Darnell, C. S. Leslie and A. Y. Rudensky: Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell, 48(5), 760-70 (2012) doi:10.1016/j.molcel.2012.10.002.
74. B. John, A. J. Enright, A. Aravin, T. Tuschl, C. Sander and D. S. Marks: Human MicroRNA targets. PLoS Biol, 2(11), e363 (2004) doi:10.1371/journal.pbio.0020363.
75. M. Kiriakidou, P. T. Nelson, A. Kouranov, P. Fitziev, C. Bouyioukos, Z. Mourelatos and A. Hatzigeorgiou: A combined computational-experimental approach predicts human microRNA targets. Genes Dev, 18(10), 1165-78 (2004) doi:10.1101/gad.1184704.
76. A. Krek, D. Grun, M. N. Poy, R. Wolf, L. Rosenberg, E. J. Epstein, P. MacMenamin, I. da Piedade, K. C. Gunsalus, M. Stoffel and N. Rajewsky: Combinatorial microRNA target predictions. Nat Genet, 37(5), 495-500 (2005) doi:10.1038/ng1536.
77. K. C. Miranda, T. Huynh, Y. Tay, Y. S. Ang, W. L. Tam, A. M. Thomson, B. Lim and I. Rigoutsos: A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell, 126(6), 1203-17 (2006) doi:10.1016/j.cell.2006.07.031.
78. M. Kertesz, N. Iovino, U. Unnerstall, U. Gaul and E. Segal: The role of site accessibility in microRNA target recognition. Nat Genet, 39(10), 1278-84 (2007) doi:10.1038/ng2135.
79. T. M. Witkos, E. Koscianska and W. J. Krzyzosiak: Practical Aspects of microRNA Target Prediction. Curr Mol Med, 11(2), 93-109 (2011).
80. M. Hafner, M. Landthaler, L. Burger, M. Khorshid, J. Hausser, P. Berninger, A. Rothballer, M. Ascano, Jr., A. C. Jungkamp, M. Munschauer, A. Ulrich, G. S. Wardle, S. Dewell, M. Zavolan and T. Tuschl: Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell, 141(1), 129-41 (2010) doi:10.1016/j.cell.2010.03.009.
81. S. W. Chi, J. B. Zang, A. Mele and R. B. Darnell: Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature, 460(7254), 479-86 (2009) doi:10.1038/nature08170.
82. A. Helwak, G. Kudla, T. Dudnakova and D. Tollervey: Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell, 153(3), 654-65 (2013) doi:10.1016/j.cell.2013.03.043.
83. R. Bruni, C. Marcantonio, E. Tritarelli, P. Tataseo, E. Stellacci, A. Costantino, U. Villano, A. Battistini and A. R. Ciccaglione: An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones. BMC Genomics, 12, 485 (2011) doi:10.1186/1471-2164-12-485.
84. M. Cheng, Y. Si, Y. Niu, X. Liu, X. Li, J. Zhao, Q. Jin and W. Yang: High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. J Virol, 87(17), 9707-18 (2013) doi:10.1128/JVI.00802-13.
85. J. Zhang, S. Li, Q. Yan, X. Chen, Y. Yang, X. Liu and X. Wan: Interferon-beta induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One, 8(12), e81366 (2013) doi:10.1371/journal.pone.0081366.
86. J. Zhang, H. Zhao, J. Chen, B. Xia, Y. Jin, W. Wei, J. Shen and Y. Huang: Interferon-ß-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett, 586(19), 3255-62 (2012) doi:10.1016/j.febslet.2012.06.047.
87. Y. Sekiya, T. Ogawa, M. Iizuka, K. Yoshizato, K. Ikeda and N. Kawada: Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-ß-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol, 226(10), 2535-42 (2011) doi:10.1002/jcp.22598.
88. G. Fiorucci, M. V. Chiantore, G. Mangino and G. Romeo: MicroRNAs in virus-induced tumorigenesis and IFN system. Cytokine Growth Factor Rev, 26(2), 183-94 (2015) doi:10.1016/j.cytogfr.2014.11.002.